We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,744 results
  1. Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer

    Despite campaigns and improvements in detection and treatment, lung cancer continues to increase worldwide and represents a major public health...

    Adriana Stuardo-Parada, Rodrigo López-Muñoz, ... Pamela Ehrenfeld in Medical Oncology
    Article 05 July 2023
  2. Kinin-kallikrein system: New perspectives in heart failure

    Heart failure (HF) is a pervasive clinical challenge characterized by compromised cardiac function and reduced quality of life. The kinin-kallikrein...

    Keivan Mohammadi, Davood Shafie, ... Majid Sadeghpour in Heart Failure Reviews
    Article 21 February 2024
  3. The relationship between clinical phenotype and kallikrein-kinin bioregulation in different forms of arthritis

    Objective

    Patients with rheumatoid arthritis (RA) have shown increased levels of neutrophils generating kallikrein-kinin peptides in blood which are...

    Dino B. A. Tan, Chantalia Tedja, ... Helen I. Keen in BMC Musculoskeletal Disorders
    Article Open access 18 May 2023
  4. Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment

    Background

    Preoperative chemotherapy/chemoradiotherapy has been generally considered for the treatment of esophageal squamous cell carcinoma (ESCC) to...

    Akira Shimomura, Teruki Hagiwara, ... Yuki I. Kawamura in Annals of Surgical Oncology
    Article 05 October 2023
  5. Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy

    Purpose

    To determine whether β-microseminoprotein or any of the kallikrein forms in blood-free, total or intact PSA or total hK2-predict metastasis in...

    Francesco Pellegrino, Daniel D. Sjoberg, ... Vincent P. Laudone in World Journal of Urology
    Article 20 May 2023
  6. Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes

    Aims/hypothesis

    Plasma kallikrein is the central mediator of the plasma kallikrein–kinin system, which is involved both in vascular control and...

    Mari-Anne Härma, Emma H. Dahlström, ... Markku Lehto in Diabetologia
    Article Open access 08 April 2020
  7. Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

    Background

    SARS-CoV-2, the virus that causes COVID-19, enters the cells through a mechanism dependent on its binding to angiotensin-converting enzyme...

    Eli Mansour, Flávia F. Bueno, ... Licio A. Velloso in Trials
    Article Open access 20 January 2021
  8. Hereditary Angioedema: Diagnosis, Pathogenesis, and Therapy

    Purpose of Review

    This review will focus on our current understanding of the pathogenesis of hereditary angioedema (HAE) and its therapy. HAE is...

    Article 02 July 2022
  9. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus

    Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection....

    Inés Valencia, Jairo Lumpuy-Castillo, ... Concepción Peiró in Cardiovascular Diabetology
    Article Open access 20 February 2024
  10. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer

    Background

    High-grade serous ovarian cancer (HGSOC) is the most common and lethal subtype of ovarian cancer. A growing body of evidence suggests...

    Weiwei Gong, Yueyang Liu, ... Viktor Magdolen in Journal of Ovarian Research
    Article Open access 21 October 2020
  11. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries

    Hereditary angioedema (HAE) is a rare autosomal dominant genetic disease characterized by repetitive subcutaneous or submucosal angioedema,...

    Yinshi Guo, Huan** Zhang, ... Rongfei Zhu in Orphanet Journal of Rare Diseases
    Article Open access 02 November 2022
  12. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma

    Lung squamous cell carcinoma (LUSC) is the second most common lung cancer worldwide, leading to millions of deaths annually. Although immunotherapy...

    He Tian, Ran Wei, ... Jie He in BMC Pulmonary Medicine
    Article Open access 25 January 2024
  13. Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers

    Introduction

    Immunoglobulin A vasculitis (IgAV) in adults has a variable disease course, with patients often develo** gastrointestinal and renal...

    Matija Bajželj, Matjaž Hladnik, ... Katja Lakota in Arthritis Research & Therapy
    Article Open access 12 April 2024
  14. A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time

    Background

    (p-BthTX-I) 2 K, a dimeric analog peptide derived from the C-terminal region of phospholipase A2-like bothropstoxin-I (p-BthTX-I), is...

    Ruben Siedlarczyk Nogueira, Bruno Ramos Salu, ... Maria Luiza Vilela Oliva in Thrombosis Journal
    Article Open access 02 January 2023
  15. Kallikrein-Related Peptidase mRNA Expression in Adenoid Cystic Carcinoma of Salivary Glands: A Polymerase Chain Reaction Study

    Kallikrein-related peptidases (KLKs) are a group of 15 serine proteases implicated in a variety of biological processes. Aberrant expression of KLKs ...

    Zachary Kerr, Alyssa Hayter, ... Mark Darling in Head and Neck Pathology
    Article 12 September 2019
  16. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology

    Hereditary angioedema (HAE) is an autosomal dominant disorder caused by a mutation in the C1 esterase inhibitor gene. HAE affects 1/50,000 people...

    Evan S. Sinnathamby, Peter P. Issa, ... Alan D. Kaye in Advances in Therapy
    Article Open access 07 January 2023
  17. Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19

    Background

    Garadacimab, a fully human IgG4 monoclonal antibody, inhibits the kallikrein–kinin pathway at a key initiator, activated coagulation factor...

    Alberto Papi, Renee D. Stapleton, ... Tobias Welte in Lung
    Article Open access 31 March 2023
  18. The kallikrein-like activity of Heloderma venom is inhibited by carbon monoxide

    Lizards in the genus Heloderma are the most ancient venomous reptiles, with a traceable lineage nearly 100 million years old. The proteome of the...

    Vance G. Nielsen, Nathaniel Frank in Journal of Thrombosis and Thrombolysis
    Article 06 April 2019
Did you find what you were looking for? Share feedback.